Join the Oncology Voice Network. Join for Free
How to overcome... "You don't have experience"
MSL career transition MSL job preparation breaking into MSL role overcoming MSL challenges MSL industry terminology

How to overcome... "You don't have experience"


Share This Article


Summary

In this episode, Mia Barnes joins Tom Caravela to discuss her journey from clinical practice to the MSL role. Mia shares insights on transitioning into the industry, highlighting the importance of working with a good recruiter and preparing effectively for job applications and interviews. They delve into overcoming common challenges faced by new MSLs, such as learning industry terminology and managing large territories. Mia emphasizes the significance of building skills, gaining exposure, and maintaining an activity journal. The conversation also touches on breaking into the MSL role with passion and specializing in specific disease states. The episode concludes with closing remarks and gratitude.

My guest today is Mia Barnes, Medical Science Liaison and we talk about how to overcome the "you don’t have enough experience" paradigm.

In this episode we discuss:

  • Mia and her background
  • Experiencing the ”You don’t have enough experience” paradigm
  • How much preparation ahead of time
  • Landing the first role and transitioning to a new team
  • Some of the things she does to establish herself in her role
  • How difficult it is to get noticed and what has worked well for Mia

Click for Source
MSL career transition, MSL job preparation, breaking into MSL role, overcoming MSL challenges, MSL industry terminology

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Mastering the Medical Affairs Professional Role: Inside and Out
Partner Avatar MSL Talk: Tom Caravela, Kent Christofferson

Mastering the Medical Affairs Professional Role: Inside and Out

Podcast
Landing My First MSL Role: From the Inside
Partner Avatar MSL Talk: Tom Caravela, Amanda Vaughn

Landing My First MSL Role: From the Inside

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Article
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
OVN Avatar Jamie Riley

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Explore OVN